This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: University of California, University of Illinois. Active years: 2017-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 16,008 
2 out of 2,424 
Years Active: 2017-2020
Title: The Innovations of Raymond M Gipson
Introduction
Raymond M Gipson is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of biochemistry, particularly in the area of cancer treatment. With a total of 3 patents, Gipson's work focuses on compounds that interact with deoxycytidine kinase, a crucial enzyme in cellular processes.
Latest Patents
Gipson's latest patents include innovative compounds that are designed to bind to deoxycytidine kinase. These compounds are not only useful for binding but also for modulating the activity of this enzyme. Additionally, he has developed deoxycytidine kinase inhibitors, which are compounds that can bind to dCK and offer methods for treating cancer effectively.
Career Highlights
Throughout his career, Gipson has worked with prestigious institutions such as the University of California and the University of Illinois. His research has been instrumental in advancing our understanding of cancer biology and therapeutic approaches.
Collaborations
Gipson has collaborated with notable colleagues, including Caius G Radu and Zheng Li. Their combined expertise has contributed to the development of innovative solutions in the field of cancer research.
Conclusion
Raymond M Gipson's contributions to the field of biochemistry and cancer treatment through his patents and collaborations highlight his role as a significant inventor. His work continues to inspire advancements in medical research and therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile